Company to host conference call at 8:00 a.m. ET on May 15 to discuss business updates and first quarter 2025 financial results CAMBRIDGE, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, ...
Highest priority programs – BEAM-101 and ESCAPE for sickle cell disease and BEAM-302 for alpha-1 antitrypsin deficiency – expected to provide foundation for meaningful value creation Company to ...
ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for the third quarter and nine months ended ...
Hosted on MSN
Solidion Technology eliminates 3.4 million warrants and derivative liabilities in strategic financing restructuring
Solidion Technology (NASDAQ:STI) has restructured a $4M equity deal, reducing dilution and boosting shareholder value, it said on Wednesday, pushing shares higher in morning trade. This strategic ...
ZOOZ Power, a provider of flywheel-based energy management solutions for ultra-fast EV charging, has announced a restructuring plan to explore strategic alternatives to leverage its patented ...
Brazilian carrier Azul received court approval on 12 December for its Chapter 11 reorganisation plan, clearing the way for the airline to emerge from the bankruptcy process early next year. Approval ...
PacBio reported Q1 2025 revenue of $37.2 million, a decrease from $38.8 million in Q1 2024, amid restructuring efforts. PacBio reported its financial results for the first quarter of 2025, revealing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results